Forums
New posts
Forum list
Search forums
What's new
New posts
New resources
Latest activity
Trending Threads
Resources
Latest reviews
Search resources
FarmTV
Farm Compare
Search
Tokens/Searches
Calendar
Upcoming Events
Members
Registered members
Current visitors
New Resources
New posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Forum list
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Agricultural Media
News, PR, Shows and Events
Commission grants approval for Elanco to acquire Bayer’s animal health business
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Agriland RSS" data-source="post: 6978768" data-attributes="member: 105608"><p><img src="https://s3-eu-west-1.amazonaws.com/files.thefarmingforum.co.uk/images/agrilanduk.JPG" alt="" class="fr-fic fr-dii fr-draggable " style="" /></p><p></p><p>Written by Agriland Team</p><p></p><p>The European Commission has granted approval to Elanco Animal Health’s pending acquisition of Bayer’s animal health business.</p><p></p><p>Elanco, the US-based company, says that it continues to move towards a mid-year closing, hoping to close the deal by August 3 , 2020.</p><p></p><p>“Approval from the European Commission is an important milestone toward the completion of our acquisition of Bayer Animal Health,” noted Jeff Simmons, president and CEO of Elanco.</p><p></p><p></p><p></p><p>“The recent months have only underscored the critical work our farmers do in delivering meat, milk, fish and eggs; and the importance of providing pet owners and veterinarians with a variety of solutions in multiple channels,” Simmons added.</p><p></p><p>Elanco says that the acquisition of Bayer’s animal health interest will strengthen its business strategy, and will advance its portfolio to create a balance between farm animal and pet businesses.</p><p></p><p>The company will also aim to diversify its pet health business into the retail and e-commerce channels.</p><p></p><p>Elanco has also undertaken divestiture agreements in the range of $120 million (€106.2 million) to $140 million (€123.9 million). The European Commission’s approval for the Bayer animal health acquisition was conditional on a number of these divestitures.</p><p></p><p></p><p>Among these are included:</p><p></p><ul> <li data-xf-list-type="ul">Divestiture of the worldwide rights for Osurnia – a treatment for otitis externa in dogs – being sold to Dechra Pharmaceuticals;</li> <li data-xf-list-type="ul">Divestiture of the worldwide rights for Vecoxan – used for prevention and treatment of coccidiosis in calves and lambs – being sold to Merck Animal Health (also known as MSD Animal Health);</li> <li data-xf-list-type="ul">Divestiture of European Economic Area and UK rights to the Drontal and Profender product families and related pipeline assets from Bayer Animal Health, being sold to Vetoquinol, a French pharmaceutical company. These products are broad-spectrum de-wormers for dogs and cats.</li> </ul><p></p><p></p><p>In addition to commission approval, Elanco has received antitrust clearance for the transaction in China, Colombia, South Africa, Turkey, Ukraine and Vietnam, as well as provisional clearance in Brazil.</p><p></p><p>The post <a href="https://www.agriland.co.uk/farming-news/commission-grants-approval-for-elanco-to-acquire-bayers-animal-health-business/" target="_blank">Commission grants approval for Elanco to acquire Bayer’s animal health business</a> appeared first on <a href="https://www.agriland.co.uk" target="_blank">Agriland.co.uk</a>.</p><p></p><p><a href="https://www.agriland.co.uk/farming-news/commission-grants-approval-for-elanco-to-acquire-bayers-animal-health-business/" target="_blank">Continue reading on the Agriland Website...</a></p></blockquote><p></p>
[QUOTE="Agriland RSS, post: 6978768, member: 105608"] [img]https://s3-eu-west-1.amazonaws.com/files.thefarmingforum.co.uk/images/agrilanduk.JPG[/img] Written by Agriland Team The European Commission has granted approval to Elanco Animal Health’s pending acquisition of Bayer’s animal health business. Elanco, the US-based company, says that it continues to move towards a mid-year closing, hoping to close the deal by August 3 , 2020. “Approval from the European Commission is an important milestone toward the completion of our acquisition of Bayer Animal Health,” noted Jeff Simmons, president and CEO of Elanco. “The recent months have only underscored the critical work our farmers do in delivering meat, milk, fish and eggs; and the importance of providing pet owners and veterinarians with a variety of solutions in multiple channels,” Simmons added. Elanco says that the acquisition of Bayer’s animal health interest will strengthen its business strategy, and will advance its portfolio to create a balance between farm animal and pet businesses. The company will also aim to diversify its pet health business into the retail and e-commerce channels. Elanco has also undertaken divestiture agreements in the range of $120 million (€106.2 million) to $140 million (€123.9 million). The European Commission’s approval for the Bayer animal health acquisition was conditional on a number of these divestitures. Among these are included: [LIST] [*]Divestiture of the worldwide rights for Osurnia – a treatment for otitis externa in dogs – being sold to Dechra Pharmaceuticals; [*]Divestiture of the worldwide rights for Vecoxan – used for prevention and treatment of coccidiosis in calves and lambs – being sold to Merck Animal Health (also known as MSD Animal Health); [*]Divestiture of European Economic Area and UK rights to the Drontal and Profender product families and related pipeline assets from Bayer Animal Health, being sold to Vetoquinol, a French pharmaceutical company. These products are broad-spectrum de-wormers for dogs and cats. [/LIST] In addition to commission approval, Elanco has received antitrust clearance for the transaction in China, Colombia, South Africa, Turkey, Ukraine and Vietnam, as well as provisional clearance in Brazil. The post [URL='https://www.agriland.co.uk/farming-news/commission-grants-approval-for-elanco-to-acquire-bayers-animal-health-business/']Commission grants approval for Elanco to acquire Bayer’s animal health business[/URL] appeared first on [URL='https://www.agriland.co.uk']Agriland.co.uk[/URL]. [url="https://www.agriland.co.uk/farming-news/commission-grants-approval-for-elanco-to-acquire-bayers-animal-health-business/"]Continue reading on the Agriland Website...[/url] [/QUOTE]
Insert quotes…
Verification
Post reply
Forums
Agricultural Media
News, PR, Shows and Events
Commission grants approval for Elanco to acquire Bayer’s animal health business
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top